’The CST technology is an idea whose time has come’
Abhishek Bhatewara, Director, Sales and Marketing, Clique Solar highlights the importance of adopting renewable energy at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story Archive
Frost & Sullivan hosts 5th edition of ’Green Manufacturing Excellence Awards and…
Three pharma companies featured in the Green Manufacturing Excellence Awards’ roll of honour this year
Chemical companies join hands for TfS initiative
In order to enhance sustainability within the supply chain the chemical companies AkzoNobel, BASF, Bayer, Clariant, Evonik…
Bridging the energy deficit
Vickram Jadhav, Vice President, Fortum India explains how the pharmaceutical industry can benefit from Combined Heat and Power…
Denied a chance of a cure
15 year-old Nidhi Shirol, who has Pompe Disease, receives life saving enzyme replacement therapy free of cost, but cannot be part…
Putting cancer on trial
Clinical trials are sometimes the only option for cancer patients to access newer drugs when standard treatment has been…
Speeding up tri@ls
Patients have so far been recruited for trials by sponsors or CROs. However, the social media bandwagon offers an interesting…
Consent by camera: When visuals dont tell the full story
The regulator has mandated AV consents as superior to the written process in terms of generating more tamper-proof evidence and…
Patient recruitment: A paralysed process?
Despite enormous patient pool availability at low cost, CROs are still battling with issues in patient recruitment for clinical…
My doctor hero
The issue of post trial access to investigational drugs has not seen as much debate in India. Express Pharma presents the…
Battling on Different Fronts
The pharma sector in Maharashtra is facing challenges from different quarters, including bureaucratic hurdles, unwarranted…
’Maharashtra is the hub of quality medicines’
Maharashtra still dominates the Indian pharma sector, emphasises Mahesh Zagade, Commissioner, FDA Maharashtra, in conversation…
Agenda for the next PM
What policy changes should be on the next Prime Minister's Agenda in order to re-vitalise the pharmaceutical industry in India?…
Healthcare A Poli-Trickal Issue
Indian political parties are busy wooing voters with myriad promises for the General Elections 2014. Yet healthcare, a vital…
Clinical trials in India Uncertainty lingers
As the Indian clinical research industry strives to adhere to the numerous changes announced last year, the delay in clearing up…
Clinical trials: Perception vs reality
As regulators and industry hammer out practical implementation strategies of India's evolving clinical trial regulations, both…
Harnessing Asia’s clinical trial potential
Lisa Marie Saldanha, Director, Head of Site Identification Services Asia, Quintiles and Dr Karen Wai, Senior Director, Head, Site…
Train to Gain
Non compliance with GMP norms has proved costly for some of the biggest Indian pharmaceutical companies. Eager to avoid such…
Initiatives by IDMA
SV Veerramani, President,IDMA, Chairman and Managing Director, Fourrts (India) Laboratories elaborates on endeavours taken by IDMA…
An arduous endeavour?
Indian pharma companies are pushing for 'third country' status from the EU regulatory authorities for India's Schedule M and GMP…